The association between adipocytokines and biomarkers for nonalcoholic fatty liver disease-induced liver injury: A study in the general population

Keyphrases

• Abdominal Obesity 33%
• Adipocytokines 100%
• Adiponectin 100%
• Confidence Interval 50%
• Etiology 16%
• Exclusion Criteria 16%
• FibroMax 33%
• Fibrosis 66%
• FibroTest 33%
• Hemoglobin A1c (HbA1c) 16%
• High-density Lipoprotein Cholesterol (HDL-C) 16%
• Inclusion Criteria 16%
• Induced Liver Injury 100%
• Insulin 33%
• Leptin 83%
• Lipids 16%
• Liver Biopsy 16%
• Liver Disease 16%
• Liver Injury 16%
• National Health Survey 16%
• Non-alcoholic Fatty Liver Disease (NAFLD) 100%
• Non-associated 16%
• Non-invasive Biomarkers 16%
• Nonalcoholic Steatohepatitis 100%
• Odds Ratio 50%
• Screening Tool 16%
• Serum Leptin 16%
• Serum Triglycerides 16%
• Significant Fibrosis 16%
• Steatohepatitis 16%
• Strong Predictor 16%
• Upper Quartile 16%

Medicine and Dentistry

• Abdominal Obesity 25%
• Adipocytokine 100%
• Adiponectin 75%
• Anthropometry 12%
• Biological Marker 100%
• Cross Sectional Study 12%
• Fibrosis 62%
• FibroTest 25%
• Health Survey 12%
• High-Density Lipoprotein 12%
• Leptin 75%
• Liver Biopsy 12%
• Liver Disease 12%
• Liver Injury 100%
• Nonalcoholic Fatty Liver 100%
• Odds Ratio 37%
• Steatohepatitis 12%
• Triacylglycerol 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Abdominal Obesity 25%
• Adipocytokine 100%
• Adiponectin 75%
• Biological Marker 100%
• Borderline State 25%
• Cross-Sectional Study 12%
• Fibrosis 62%
• Health Survey 12%
• High Density Lipoprotein 12%
• Leptin 75%
• Liver Disease 12%
• Liver Injury 100%
• Nonalcoholic Fatty Liver 100%
• Triacylglycerol 12%